Endocrine Sequelae in Childhood Cancer Survivors

• Autores: Sobenna A. George, Karen E. Effinger, Lillian R. Meacham
• Localización: Endocrinology and metabolism clinics of North America, ISSN 0889-8529, Vol. 49, Nº. 4, 2020 (Ejemplar dedicado a: Pediatric Endocrinology), págs. 565-587
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • The 5-year survival rate for childhood cancer survivors is currently greater than 80% in developed countries. However, survivors may have an increased risk of endocrine toxicities from their tumors or their treatments. Although some endocrinopathies are apparent soon after cancer therapy completion, others manifest years later; therefore, long-term surveillance is crucial. This article reviews the association between cancer treatments and endocrine late effects. It also summarizes recommendations regarding surveillance for endocrine late effects and referrals to endocrinologists based on treatment exposures. In addition, this article provides special considerations for the treatment of endocrinopathies in survivors. © 2020 Elsevier Inc.